Showing results (681-690 of 2,364) with videos related to

Sort By:
Pageof 237
Mutation Research|December 1, 1985
Structure-genotoxic activity relationships of pesticides: comparison of the results from several short-term assaysG Klopman, R Contreras, H S Rosenkranz, et al.
Diabetes Research and Clinical Practice|March 10, 2022
The impact of high-intensity interval training on postprandial glucose and insulin: A systematic review and meta-analysisMousa Khalafi, Ali A Ravasi, Abbas Malandish, et al.
Brain Stimulation|July 17, 2010
Consensus paper: use of transcranial magnetic stimulation to probe motor cortex plasticity in dystonia and levodopa-induced dyskinesiaAngelo Quartarone, Joseph Classen, Francesca Morgante, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysisP Mendes, N Lameire, B Rosenkranz, et al.
Mutation Research|March 20, 1999
Thalidomide and metabolites: indications of the absence of 'genotoxic' carcinogenic potentialsX Zhu, Y P Zhang, G Klopman, et al.
Wiener Klinische Wochenschrift|January 1, 1995
Molecular and clinical findings in Austrian cystic fibrosis patients with mutations in exon 11 of the CFTR geneI Greil, K Wagner, E Eber, et al.
Radiologia Diagnostica|January 1, 1989
[Computed tomographic diagnosis of rectal tumors]J Freitag, M Rosenkranz, G Freitag, et al.
Optics Express|March 26, 2014
Initial ranging scheme based on interpolated Zadoff-Chu sequences for OFDMA-PONAli Razmtouz, Kai Habel, Christoph Kottke, et al.
Expert Opinion on Investigational Drugs|January 9, 2003
Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)Lucila M A Agle, Margalit Rosenkranz, Thomas J A Lehman
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 1, 1994
Structural determinants of developmental toxicityN Takihi, H S Rosenkranz, G Klopman, et al.
Pageof 237